FDA Gives LivaNova Approval for Aura6000 Clinical Study for Obstructive Sleep Apnea

This randomized controlled trial will take place at approximately 20 sites across the United States and will enroll a maximum of 150 adult patients with moderate to severe OSA who do not achieve results from a traditional CPAP machine or have declined its use.

Leave a Reply